Data as of Aug 01
| +0.58 / +2.99%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 45.87, with a high estimate of 66.06 and a low estimate of 15.10. The median estimate represents a +129.67% increase from the last price of 19.97.
The current consensus among 7 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.